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Abstract
Background: To investigate the clinical characteristics, angiographic findings and clinical outcomes 
(in-hospital) of young adults with acute myocardium infarction in a Chinese population.
Methods: This was an observational study. Five hundred and forty-nine patients who suffered with 
ST-segment elevation myocardial infarction (STEMI) firstly between January 2013 and December 2015 
were enrolled consecutively. All patients were divided into two groups: “young group” patients were  
≤ 50 years old; and “non-young group” patients were > 50 years old. Clinical features were compared, 
angiographic findings and clinical outcomes were observed between the two groups.
Results: There were 131 and 418 patients included in the young group and the non-young group, re-
spectively. Twenty-eight patients suffered deaths during the hospital stay and only one death occurred in 
the young group. Compared with non-young group, the young group was associated with male, smoke, 
fewer chronic diseases, Killip class I on admission, lower level of N-terminal pro B-type natriuretic 
peptide (NT-proBNP), higher level of triglyceride and lower level of high-density lipoprotein cholesterol 
(HDL-C), single-vessel lesion and intracoronary thrombus (p < 0.005). The average length of hospital 
stay of non-young group was 1.5 days longer than the young group. Compared with the non-young 
group, the young group inclined not to use or use only one stent (p = 0.026). Multivariable logistic 
regression analysis showed that older age, shorter hospital stay, advanced Killip class III/IV, increased 
white blood cell and NT-proBNP were independent risk factors for survival in acute STEMI patients 
during hospitalization (p < 0.005).
Conclusions: Compared with non-young group, the young group was associated with male, smoke, 
higher level of triglyceride and lower level of HDL-C. The condition of patients in young group were 
relatively mild and the risk of death during hospitalization was lower than the other group. (Cardiol J ) 
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Introduction 
During the last decades, cardiovascular dis-
ease has become the single largest cause of death in 
the worldwide [1]. Although mortality in coronary 
heart disease has markedly reduced in Western 
societies over the past few decades [2], while the 
age-adjusted death rate is still increasing in many 
low- and middle-income countries [3]. Coronary 
heart disease is emerging as a large and grow-
ing burden in China. Data from the China health 
statistics year book 2020 has shown that coronary 
heart disease accounted for almost 80% of overall 
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tion (AMI) is the leading cause of death of patients 
hospitalized for cardiovascular disease. This new 
health problem is mostly due to the transition of 
socioeconomics and individual lifestyle, including 
urban migration patterns, rapid urban moderniza-
tion, unhealthy dietary changes, increased tobacco 
use, and less physical inactivity [3, 4]. The summa-
ry exposure values for high body mass index, high 
blood pressure, high fasting plasma glucose and 
high low-density lipoprotein cholesterol (LDL-C) 
increased year by year in the young population 
from 1990 to 2017 [3]. Coronary heart disease af-
flicts a younger population and increased deaths of 
the working-age population. The clinical features 
and outcomes of AMI in the young population are 
considered to be different from those in the non-
-young population. However, there is few data to 
address these issues in the Chinese population. 
Therefore, we sought to investigate the clinical 
characteristics, angiographic findings and clinical 
outcomes (in-hospital) of young adults with AMI 
in a Chinese population.
Methods
Study design
This is an observational study. All patients who 
suffered from ST-segment elevation myocardial 
infarction (STEMI) firstly between January 2013 
and December 2015 were enrolled consecutively. 
Patients who did not immediately receive coronary 
angiography were excluded. STEMI is defined as 
patients with persistent chest discomfort or other 
symptoms suggestive of myocardial ischemia and 
electrocardiographic ST-segment elevation in at 
least two contiguous leads (12-lead electrocar-
diogram), and subsequent release of biomarkers 
of myocardial necrosis, including creatine kinase 
isomer-MB and troponin I. After the attack of 
symptoms of myocardial ischemia, patients were 
admitted to Chest Pain Center of the documented 
hospital as soon as possible. Once the diagnosis 
was considered, green channel was opened im-
mediately. Most patients received primary percu-
taneous coronary intervention (PCI) except a few 
of them refused it for their own reasons or did not 
survive to receive this procedure. This study was 
conducted in accordance with the amended Decla-
ration of Helsinki, and the protocol was approved 
by the Institutional Review Boards.
Patients
Finally, 549 eligible patients were enrolled 
from the Chest Pain Center during this period. All 
of the patients were divided into two groups: the 
“young group” in which patients were ≤ 50 years 
old; and the “non-young group” in which patients 
were > 50 years old. Managements for all of the 
patients were given according to individual clinical 
condition.
PCI procedures
Percutaneous coronary intervention was per-
formed using standard techniques. A transradial 
approach using a 6-F arterial sheath was performed 
routinely, unless bilaterally upper extremity arter-
ies tortuosity, stenosis or occlusion leading to guid-
ing failed to pass through. An off-line, computer- 
-based software (Innova 2100 Digital Cardiovas-
cular System Revolution of Cardiology, USA) 
was used for quantitative coronary angiographic 
analysis. Significant coronary artery stenosis was 
defined as at least a 75% reduction in the internal 
diameter of the left anterior descending, left cir-
cumflex or right coronary artery and their major 
branches, or a 50% reduction in the internal diam-
eter of the left main trunk assessed visually during 
coronary angiography. Multivessel disease was 
defined as the presence of a significant coronary 
artery atherosclerotic stenosis (≥ 70% diameter 
stenosis) in at least two arteries or a ≥ 50% diam-
eter stenosis of the left main coronary artery (left 
main disease) with additional significant stenosis (≥ 
70% diameter stenosis) of at least one other coro-
nary artery. Gensini score, integrating the degree 
and locations of stenosis, was applied to analyze the 
severity of coronary artery disease. Thrombolysis 
in Myocardial Infarction (TIMI) flow grades in the 
culprit coronary artery were confirmed at the be-
ginning and end of the procedure. The former-TIMI 
was defined as the TIMI flow grade recorded before 
PCI, and the latter-TIMI as the TIMI flow grade 
recorded after PCI. Choices concerning whether 
or not to implant stents, bare-metal or drug-eluting 
type and other interventional measures were left 
to the discretion of the interventional cardiologist. 
Intracoronary thrombus was defined as ≥ 1 filling 
defect at the site of lesion in the absence of a major 
dissection. Transcatheter thrombus aspiration was 
used in patients with massive thrombus in coronary 
arteries which resulted in blood flow obviously 
slow or even occluded. Intra-aortic balloon pump 
was used to support the circulation in patients 
experiencing cardiogenic shock and performed 
before, during or after PCI. Patients with severe 
atrioventricular block were implanted with tem-
porary pacemakers. PCI success was defined as 
a combination of TIMI flow grade resumed to 3 of 
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distal portion of coronary arteries and the residual 
diameter stenosis ≤ 30% after procedure. 
Ticagrelor (180 mg loading dose) or clopi-
dogrel (300–600 mg loading dose) was given to 
patients undergoing primary PCI in the emergency 
room before cardiac catheterization. And then tica-
grelor (180 mg/day) or clopidogrel (75 mg/day) was 
maintained each day. After 300 mg loading dose, 
acetylsalicylic acid (100 mg orally once daily) was 
given identically to each patient.
Definitions and outcomes
Detailed personal information, including age, 
gender, marital status, past medical history of hy-
pertension, diabetes mellitus, stroke, smoking and 
drinking, was collected at the time of admission. 
Systolic blood pressure, diastolic blood pressure, 
heart rate and Killip score were all evaluated at 
the same time. Laboratory parameters were tested 
at the next morning after admission. N-terminal 
pro B-type natriuretic peptide (NT-proBNP) was 
evaluated within 72 h after PCI. Left ventricular 
ejection fraction was assessed by transthoracic 
echocardiography within 72 h after primary PCI. 
In-hospital outcomes included length of hos-
pital stay, all-cause mortality (non-cardiac and car-
diac death), major adverse cardiac event (MACE) 
and hemorrhage. MACE defined as a composite 
endpoint of infection, stroke, target vessel revas-
cularization, new onset atrial fibrillation, severe 
atrioventricular block, sustained ventricular tachy-
cardia/fibrillation, left ventricular mural thrombo-
sis, ventricular rupture, congestive heart failure 
and in-hospital death. Bleeding mainly contained 
visceral hemorrhage and iatrogenic hemorrhage 
caused by operations.
Statistical analysis
Descriptive data for continuous variables with 
Gaussian distribution were presented as the mean 
± standard deviation (SD). Descriptive data for 
discrete variables were presented as the frequency 
(percentage). Patient characteristics were com-
pared between the young and non-young groups 
using the independent Student t test, c2 test, or the 
Fisher exact test as appropriate. Survival curves 
were calculated by the Kaplan–Meier method and 
compared using a log-rank test. Univariate logistic 
regression analyses were performed to identify 
variables related to MACE during in-hospital time. 
All variables with a p < 0.05 were then tested in 
a forward stepwise multivariate logistic regression 
analysis. Data were expressed as hazard ratio with 
95% confidence interval. A p value < 0.05 was 
considered to indicate statistical significance. All 
analyses were performed using SPSS 13.0 software 
(SPSS Inc., Chicago, IL, USA).
Results 
Among all of the patients, there were 131 and 
418 patients in the young group and the non-young 
group, respectively. Table 1 showed the baseline 
clinical characteristics of the patients. Male sex, 
smoke/current smoker, Killip class I at presenta-
tion, lower diastolic blood pressure and higher 
heart rate were more frequently observed in the 
young group. In contrast, hypertension and stroke 
were more frequently observed in the non-young 
group. Medication at discharge as shown in Table 1 
did not differ significantly between the two groups.
Comparisons of laboratory parameters between 
the young group and non-young group were shown 
in Table 2. The young group patients had signifi-
cantly higher counts of white blood cell and plate-
let, as well as level of hemoglobin and triglyceride 
(Ps < 0.05). Non-young group patients had signifi-
cantly high-density lipoprotein cholesterol (HDL-C), 
urea, creatinine and Lg proBNP (Ps < 0.05). 
There were no differences between the two groups 
in uric acid, LDL-C, non-HDL-C, fasting blood 
glucose, C-reactive protein or troponin I.
Comparisons of the angiographic findings, 
procedural details and interventional strategies 
were shown in Table 3. One patient died of cardiac 
rupture just after radial artery puncture during 
coronary angiography. Gensini score in both groups 
did not differ significantly (p = 0.089). The young 
group patients were more likely to have had single 
vessel disease than the non-young group patients. 
The percentages of intracoronary thrombus in the 
young group and the non-young group were 39.7% 
and 29.3% (p = 0.025). Rates of PCI in both groups 
were greater than 95%. The average time period 
from symptom onset to PCI of diseased vessels of 
the all patients was 128.28 ± 96.24 min. Patients 
from the non-young group were more inclined to 
undergo PCI of a culprit lesion than patients from 
the young group (p = 0.022). No use of stent was 
more frequently observed in the young group. 
Compared with the non-young group, the young 
group inclined not to use or use only one stent 
(p = 0.026). Mean stent diameter in the young 
group was likely larger than that in the non-young 
group (p = 0.061). 
Table 4 showed the in-hospital outcomes for 
the two groups. There were 28 deaths during hospi-
talization. Only 1 death occurred in the young group 
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for which the cause was of cardiogenic shock. The 
other 27 deaths occurred in the non-young group, 
including 11 for cardiogenic shock, 9 for ventricular 
rupture, 3 for malignant ventricular arrhythmia, 2 
for pericardial tamponade, 1 for cerebrovascular 
accident and 1 for electrical mechanical disso-
ciation. The young group had a shorter length of 
hospital stay than the non-young group. And the 
frequency of infection and congestive heart failure 
were less common observed in the young group. 








Age [years] 60.43 ± 13.36 42.50 ± 6.33 66.05 ± 9.46 0.000
Death 28 (5.1%) 1 (0.8%) 27 (6.5%) 0.010
Male 476 (86.7%) 125 (95.4%) 351 (84.0%) 0.000
Not-married 14 (2.6%) 7 (5.3%) 7 (1.7%) 0.490
Risk factor:
Hypertension 330 (60.1%) 46 (35.1%) 284 (67.9%) 0.000
Diabetes 111 (20.2%) 21 (16.0%) 90 (21.5%) 0.171
Current smoker 348 (63.4%) 107 (81.7%) 241 (57.7%) 0.000
Smoke 375 (68.3%) 109 (83.2%) 266 (63.6%) 0.000
Gout 14 (2.6%) 1 (0.8%) 13 (3.1%) 0.205
Stroke 36 (6.6%) 2 (1.5%) 34 (8.1%) 0.008
Killip class: 0.022
I 437 (79.6%) 116 (88.5%) 321 (76.8%)
II 76 (13.8%) 12 (9.2%) 64 (15.3%)
III 9 (1.6%) 1 (0.8%) 8 (1.9%)
IV 27 (4.9%) 2 (1.5%) 25 (6.0%)
Left ventricular ejection [mm] 48.53 ± 9.78 49.04 ± 10.33 48.36 ± 9.59 0.498
Location of infarction:
Anterior 204 (37.2%) 49 (37.4%) 155 (37.1%) 0.611
Inferior 211 (38.4%) 44 (33.6%) 167 (40.0%)
Lateral 7 (1.3%) 2 (1.5%) 5 (1.2%)
Extensive anterior wall 107 (19.5%) 31 (23.7%) 76 (18.2%)
Other 20 (3.6%) 5 (3.8%) 15 (3.6%)
Systolic blood pressure [mmHg] 121.47 ± 22.99 124.04 ± 20.74 120.67 ± 23.61 0.143
Diastolic blood pressure [mmHg] 75.53 ± 14.90 79.08 ± 15.38 74.41 ± 14.59 0.002
Heart rate [bpm] 80.87 ± 16.81 83.42 ± 16.64 80.07 ± 16.80 0.046
Medication at discharge:
Acetylsalicylic acid 506 (97.3%) 128 (98.5%) 378 (96.9%) 0.534
Clopidogrel/ticagrelor 503 (96.7%) 125 (96.2%) 378 (96.9%) 0.776
Statins 514 (98.8%) 129 (99.2%) 385 (98.7%) 1.000
Beta-blocker 437 (84.0%) 108 (83.1%) 329 (84.4%) 0.730
ACEI/ARB 324 (62.3%) 81 (62.3%) 243 (62.3%) 1.000
Calcium channel blocker 18 (3.5%) 7 (5.3%) 11 (2.8%) 0.172
Diuretics 40 (7.7%) 7 (5.4%) 33 (8.5%) 0.254
Digoxin 14 (2.7%) 1 (0.8%) 13 (3.3%) 0.206
Spirolactone 139 (26.7%) 40 (30.8%) 99 (25.4%) 0.230
Warfarin 7 (1.3%) 3 (2.3%) 4 (1.0%) 0.303
ACEI/ARB — angiotensin converting enzyme inhibitor/angiotensin receptor blocker
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There were no differences in the MACE between 
the two groups. There was a significant difference 
in the cumulative survival rates between the two 
groups during hospitalization (p = 0.015, Fig. 1). 
Multivariable logistic regression analysis showed 
that older age, shorter hospital stay, advanced Kil-
lip class III/IV, increased white blood cell and NT-
-proBNP were independent risk factors for survival 
in acute STEMI patients during hospitalization 
(p < 0.005, Table 5).
Discussion
In this study, clinical characteristics of STEMI 
among 131 young patients (≤ 50 years old) and 
418 non-young patients (> 50 years old) were 
compared. When comparing the groups, the young 
group patients were associated with male sex, 
smoke/current smoke, lower Killip class, hyper-
lipidemia, higher level of hemoglobin, lower level 
of NT-proBNP. Single diseased vessel, intracoro-
nary thrombus and single stent implant were more 
common in the young group. Infection, congestive 
heart failure and mortality were lower in the young 
group compared to the non-young group. 
Previous studies reported that the young AMI 
patients had a higher proportion of males and cur-
rent smokers than non-young patients [5–11]. The 
findings of the present study were in accordance 
with these studies. Smoking accounts for 80% to 
90% of young AMI patients and was emerging as 
the main coronary risk factor [6, 7, 12]. In con-
temporary society, two–thirds of Chinese males 
smoked. Among Chinese women, however, there 
has been a tenfold intergenerational reduction 
in smoking uptake rates. The tobacco-attributed 
proportion was increasing in men, but was low and 
decreasing, in women [13]. Therefore, smoke was 
more prevalent in young Chinese patients than 
older ones. Former researchers have reported 
that the prevalence of chronic diseases, such as 
hypertension, diabetes mellitus and stroke in the 
young patients were lower in the young patients 
than that in the non-young patients [6, 8, 10, 11, 14, 
15]. In the present study, the prevalence of chronic 
disease was also in accordance with these trends, 
although the diabetes mellitus was not significant. 
It was interesting that it was found the young 
STEMI patients had a significantly higher level of 
triglyceride and lower level of HDL-C than that 
of the older patients, while total cholesterol and 
LDL-C did not differ significantly. The latest stud-
ies also indicated that young patients with STEMI 
had a higher level of non-HDL-C and triglyceride 
[16, 17]. In a modern lifestyle, the increased level 
of triglyceride might be associated with decreased 
physical activity and increased fat mass [18]. 
Triglyceride-rich lipoproteins are associated with 
Table 2. Laboratory parameters.
Laboratory parameter All Young group Non-young  
group
P
Hemoglobin [g/L] 504 138.19 ± 20.36 121 148.10 ± 13.55 383 135.06 ± 21.15 0.000
White blood cell [109/L] 505 10.69  ± 3.53 121 11.69 ± 3.40 384 10.37 ± 3.52 0.000
Platelet [109/L] 505 204.13 ± 65.08 121 226.36 ± 60.41 384 197.93 ± 64.99 0.000
Uric acid [µumol/L] 542 346.38 ± 113.95 131 347.78 ± 111.53 411 345.93 ± 114.84 0.870
TC [mg/dL] 540 4.54 ± 1.10 130 4.60 ± 1.12 410 4.52 ± 1.09 0.516
LDL-C [mg/dL] 540 2.90 ± 0.96 130 2.99 ± 0.99 410 2.87 ± 0.95 0.230
HDL-C [mg/dL] 540 1.07 ± 0.23 130 1.02 ± 0.19 410 1.09 ± 0.24 0.001
Triglyceride [mg/dL] 539 1.58 ± 1.57 130 2.02 ± 1.74 409 1.44 ± 1.49 0.000
Non-HDL-C [mg/dL] 540 3.47 ± 1.07 130 3.58 ± 1.09 410 3.43 ± 1.06 0.178
FBG [mmol/L] 540 6.92 ± 3.14 130 6.51 ± 2.79 410 7.05 ± 3.24 0.062
hs-CRP [mg/L] 542 7.69 ± 4.75 131 7.27 ± 4.54 411 7.83 ± 4.81 0.228
Urea [mmol/L] 544 5.61 ± 2.45 131 4.71 ± 1.47 413 5.90 ± 2.62 0.000
Creatinine [µmol/L] 545 80.83 ± 40.38 131 70.04 ± 15.89 414 84.24 ± 44.94 0.000
Troponin I [pg/mL] 499 49.98 ± 30.27 118 49.62 ± 29.89 381 50.09 ± 30.43 0.881
Lg pro-BNP 396 3.03 ± 0.52 92 2.78 ± 0.55 304 3.10 ± 0.49 0.000
BNP — B-type natriuretic peptide; FBG — fasting blood glucose; HDLC — high-density lipoprotein cholesterol; hs-CRP — high sensitivity reac-
tive protein; LDL-C — low-density lipoprotein cholesterol; TC — total cholesterol
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increased rates of progression of atherosclerotic 
lesions [19]. During the progression of athero-
sclerosis, inflammatory cells destabilize lipid-rich 
plaques in the arterial wall and cause their rup-
tures, thus triggering myocardial infarction and 
stroke [20]. The findings of the current study 
also confirmed that the count of white blood cells 
and the level of triglyceride were both increased 
in the young group. Thus, it may be a warning to 
pay more attention to the level of triglyceride in 
young patients. Progressively reducing the level 
of triglyceride would benefit young adults in the 
prevention of cardiovascular events.
In the present study, the percentage of PCI 
and the use of stents were lower in the young 
group than that in the non-young group. It might 
have been related to many factors, such as not 
severe residual stenosis of culprit coronary ar-
tery, high-burden intracoronary thrombus, coro-
nary vasospasm and individual choice [6]. It was 
found that single-vessel lesion and intracoronary 
thrombus were much more common in young 
patients. And, Gensini score in the young group 
seemed lower than that in the non-young group, 
though not significant. These findings were con-
sistent with previous studies and explained rea-
sons of the relatively low utilization rate of stent 
[17]. Young patients had a higher probability of 
angiographically normal or mildly obstructed 
coronary arteries than their older counterparts [7]. 
Table 3. Angiographic findings and intervention.
Patient characteristics All Young group Non-young group P
PCI 541 (98.5%) 126 (96.2%) 415 (99.3%) 0.022
Gensini score 54.88 ± 30.38 51.18 ± 27.57 56.04 ± 31.15 0.089
Number of diseased vessels: 0.000
1 314 (57.3%) 97 (74.0%) 217 (52.0%)
2 155 (28.3%) 25 (19.1%) 130 (31.2%)
3 79 (14.4%) 9 (6.9%) 70 (16.8%)
Intracoronary thrombus 174 (31.8%) 52 (39.7%) 122 (29.3%) 0.025
Time period from symptom onset to PCI [min] 128.28 ± 96.24 129.71 ± 87.50 127.85 ± 98.82 0.853
Initial TIMI: 0.554
0 417 (76.1%) 94 (71.8%) 323 (77.5%)
1 19 (3.5%) 5 (3.8%) 14 (3.4%)
2 51 (9.3%) 15 (11.5%) 36 (8.6%)
3 61 (11.1%) 17 (13.0%) 44 (10.6%)
After TIMI: 0.219
0 4 (0.7%) 0 4 (1.0%)
1 4 (0.7%) 0 4 (1.0%)
2 27 (5.0%) 3 (2.4%) 24 (5.8%)
3 505 (93.5%) 124 (97.6%) 381 (92.3%)
After-initial TIMI 2.37 ± 1.11 2.35 ± 1.10 2.37 ± 1.11 0.863
Stent: 0.026
0 132 (24.1%) 39 (29.8%) 93 (22.3%)
1 397 (72.4%) 91 (69.5%) 306 (73.4%)
2 19 (3.5%) 1 (0.8%) 18 (4.3%)
Stent type:
Mean total stent length [mm] 23.87 ± 7.12 23.37 ± 6.59 24.01 ± 7.27 0.445
Mean stent diameter [mm] 2.99 ± 0.34 3.05 ± 0.33 2.97 ± 0.35 0.061
Bare metal stent use 37 (8.9%) 8 (8.7%) 29 (9.0%) 1.000
Drug-eluting stent use 379 (91.1%) 84 (91.3%) 295 (91.0%)
Transcatheter thrombus aspiration 63 (11.5%) 20 (15.3%) 43 (10.3%) 0.156
PCI — percutaneous coronary intervention; TIMI — Thrombolysis in Myocardial Infarction
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Table 4. In-hospital outcome.
All Young group Non-young group P 
Length of hospital stay [day] 9.49 ± 7.38 8.36 ± 3.54 9.84 ± 8.12 0.004
Motality 28 (5.1%) 1 (0.8%) 27 (6.5%) 0.006
Bleeding 16 (2.9%) 2 (1.5%) 14 (3.3%) 0.381
Infection 54 (9.8%) 5 (3.8%) 49 (11.7%) 0.007
Stroke 4 (0.7%) 0 4 (1.0%) 0.577
Stent thrombosis 5 (0.9%) 2 (1.5%) 3 (0.7%) 0.343
New onset of atrial fibrillation 35 (6.4%) 4 (3.1%) 31 (7.4%) 0.099
New onset of atrial ventricular block 37 (6.7%) 6 (4.6%) 31 (7.4%) 0.321
Sustained VT/VF 43 (7.8%) 9 (6.9%) 34 (8.1%) 0.713
Left ventricular thrombus 6 (1.1%) 3 (2.3%) 3 (0.7%) 0.151
Ventricular rupture 10 (1.8%) 0 10 (2.4%) 0.128
Congestive heart failure 98 (17.9%) 11 (8.4%) 87 (20.8%) 0.001
Ventricular aneurysm 27 (4.9%) 5 (3.8%) 22 (5.3%) 0.646
Hypotension 99 (18.0%) 19 (14.5%) 80 (19.1%) 0.229
Acute hepatic/renal dysfunction 31 (5.6%) 7 (5.3%) 24 (5.7%) 1.000
Required blood transfusion 3 (0.5%) 0 3 (0.7%) 1.000
VT/VF — ventricular tachycardia/ventricular fibrillation
Figure 1. Kaplan-Meier curves estimated of the cumula-
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For the patients with intracoronary thrombus, we 
inclined to use transcatheter thrombus aspiration, 
intracoronary tirofiban, intracoronary balloon dila-
tation or delayed stenting according to the burden 
of thrombus. Delayed stenting is safe and feasible 
for STEMI patients with high-burden thrombus 
who have undergone initial thrombus aspiration, 
and may be associated with better immediate 
myocardial perfusion, more left ventricular func-
tion recovery, and less occurrence of major adverse 
cardiovascular events at 1-year follow-up [21]. 
Although the incidence of intracoronary thrombus 
was high in the young group, lower mortality and 
shorter length of hospital stay were more common 
in the young group than that in the non-young 
group. Results of this study indicated that intrac-
oronary thrombus per se, might not be a risk factor 
of major adverse cardiovascular events. 
In the previous studies, favorable hospital 
outcomes in the young AMI patients were reported 
[6, 7, 22–25]. The present study showed that mor-
tality, infection and congestive heart failure were 
lower in the young group than in the non-young group. 
At the same time, it was found that the prevalence of 
Killip class I, low level of NT-proBNP, single-vessel 
lesion and short length of hospital stay were more 
common in the young group patients. All of these 
indexes indicated a relatively mild condition and 
prognosis of the young patients would be better 
than the non-young patients. Younger age per se, 
is a significant independent indicator of a favorable 
prognosis after AMI [24]. The results of the current 
study were similar with previous studies, which 
reported that the prevalence of Killip I and single-
-vessel lesion in the young groups was higher than 
in the non-young groups [6, 8, 10, 11]. Infection 
and congestive heart failure during hospitalization 
were more often observed in the non-young group 
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Table 5. Multivariate logistic regression analysis of risk factors.
Variables Univariate Cox analysis
HR (95% CI)
P Multivariate Cox analysis
HR (95% CI)
P
Age [years] 1.108 (1.064–1.155) 0.000 1.180 (1.052–1.324) 0.005
Length of hospital stay [day] 0.558 (0.466–0.667) 0.000 0.769 (0.646–0.916) 0.003
Advanced Killip class (III/IV) 50.300 (20.353–124.310) 0.000 33.099 (3.846–284.861) 0.001
White blood cell [109/L] 1.395 (1.254–1.551) 0.000 1.720 (1.264–2.339) 0.001
Lg NT-proBNP 45.249 (11.164–183.408) 0.000 69.794 (4.157–1171.878) 0.003
CI — confidence interval; HR — hazard ratio; NT-proBNP — N-terminal pro-B-type natriuretic peptide
might have increased the length of hospital stay 
and indicated an adverse outcome.
Limitations of the study
Since this study was an observational, retrospec-
tive and single-center study, selection bias might be 
an interference factor. The groups were uneven in 
size and there were many between-group differences 
in baseline and preprocedural characteristics. Some 
issues inherent to this type of study were related to 
retrospective data collection and analysis of the data. 
More young patients with AMI enrolled into prospec-
tive and multi-center study would be help to confirm 
our findings. The present study did not focus on the 
long-term survival data. And survival data should 
surely be indicated in future studies.
Conclusions
Compared with the non-young group, the young 
group was associated with male, smoke, less chronic 
diseases, lower Killip class on admission, lower level 
of NT-proBNP, higher level of triglyceride and lower 
level of HDL-C, single-vessel lesion and intracoro-
nary thrombus. Infection and congestive heart fail-
ure were less common observed in young patients 
than non-young patients during hospitalization. Old 
age, shorter hospital stay, advanced Killip class III/IV, 
increased white blood cell and NT-proBNP were 
independent risk factors for survival in acute STEMI 
patients during hospitalization.
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